hsa_circ_0001377 promotes hepatic fibrosis by sponging let-7a-5p and targeting TGFBR1, Smad2, and Col1a2
- 1Department of Pathology, Medical School of Nantong University , , ,
- 2Department of Pathology, Second Affiliated Hospital of Naval Medical University , ,
Abstract
Background : Hepatic fibrosis (HF) is primarily driven by the activation of hepatic stellate cells (HSCs) and is characterized by excessive extracellular matrix (ECM) accumulation. Circular RNAs (circRNAs) have recently gained increasing attention in HF research.
Methods : RNA sequencing and bioinformatic analyses revealed elevated hsa_circ_0001377 expression in human HF tissues. Its circular structure and subcellular localization were identified using Sanger sequencing, RNase R treatment, and fluorescence in situ hybridization (FISH). Gain- and loss-of-function experiments were conducted to elucidate the role of hsa_circ_0001377 in the human HSC line LX-2. Furthermore, the in vitro and in vivo effects of the hsa_circ_0001377/let-7a-5p/TGFBR1, Smad2, and Col1a2 regulatory axis were investigated using cytological assays and a bile duct ligation (BDL)-induced mouse model of HF.
Results : hsa_circ_0001377 was significantly upregulated in the circRNA expression profile of human HF tissues. Its circular structure was validated through Sanger sequencing and resistance to RNase R digestion. FISH and co-staining with α-SMA demonstrated that hsa_circ_0001377 was abundantly expressed in activated HSCs (aHSCs; α-SMA-positive cells). Gain- and loss-of-function assays were performed using LX-2 cells with stable hsa_circ_0001377 overexpression and a specific siRNA targeting this circRNA. hsa_circ_0001377 overexpression promoted LX-2 cell activation, proliferation, migration, and G1/S-phase transition, whereas its knockdown produced the opposite effects. qRT-PCR, AGO-RIP, dual-luciferase reporter, and miRNA pulldown assays confirmed that hsa_circ_0001377 acts as a molecular sponge for let-7a-5p and that let-7a-5p targets TGFBR1, Smad2, and Col1a2. Rescue experiments in LX-2 cells further demonstrated that hsa_circ_0001377 promotes HSC activation, proliferation, migration, and G1/S-phase transition through the let-7a-5p/TGFBR1, Smad2, and Col1a2 axis. Moreover, hsa_circ_0001377 was highly expressed in 20 human HF samples, and its expression increased with advancing fibrosis stage. In vivo , a BDL-induced murine HF model demonstrated that the homologous mmu_circ_0001377 was also significantly upregulated in fibrotic liver tissues. In addition, tail-vein injection of an mmu-let-7a-5p agomir into BDL-induced HF mice confirmed the inhibitory effects of the let-7a-5p/TGFBR1, Smad2, and Col1a2 axis on α-SMA expression and collagen deposition.
Conclusion : Taken together, these findings suggest that the hsa_circ_0001377/let-7a-5p/TGFBR1, Smad2, and Col1a2 regulatory axis may represent a promising therapeutic target for HF.
Related
- Nicotinamide N-methyltransferase couples inflammation and epigenetic remodelling to hepatic fibrosis
- Mechanosignaling Promotes Macrophage Apoptosis Resistance in Pulmonary Fibrosis via Metabolic Reprogramming
- Hepatic stellate cell FXR signaling regulates context-dependent functions in liver homeostasis and fibrosis.
- RUNX1‐Mediated Hypoxic Signaling Impairs Myogenesis and Promotes Fibrosis in Myopathies
- Circ_0024390 promotes renal tubular EMT through the miR-6890-3p/CHD4 axis: implications for renal interstitial fibrosis
BibTeX
@article{zhou2026hsacirc0001377,
title = {{hsa_circ_0001377 promotes hepatic fibrosis by sponging let-7a-5p and targeting TGFBR1, Smad2, and Col1a2}},
author = {Jiaming Zhou and Jiaxuan Liu and Dikun Wu and Junjie Ding and Binbin Li and Hongyu Yu},
journal = {Frontiers in pharmacology},
year = {2026},
month = oct,
doi = {10.3389/fphar.2026.1882205},
url = {https://europepmc.org/article/PMC/PMC13671924},
note = {CC BY},
}
RIS
TY - JOUR
TI - hsa_circ_0001377 promotes hepatic fibrosis by sponging let-7a-5p and targeting TGFBR1, Smad2, and Col1a2
AU - Jiaming Zhou
AU - Jiaxuan Liu
AU - Dikun Wu
AU - Junjie Ding
AU - Binbin Li
AU - Hongyu Yu
PY - 2026
DA - 2026/10/02
JO - Frontiers in pharmacology
DO - 10.3389/fphar.2026.1882205
UR - https://europepmc.org/article/PMC/PMC13671924
AB - Background : Hepatic fibrosis (HF) is primarily driven by the activation of hepatic stellate cells (HSCs) and is characterized by excessive extracellular matrix (ECM) accumulation. Circular RNAs (circRNAs) have recently gained increasing attention in HF research. Methods : RNA sequencing and bioinformatic analyses revealed elevated hsa_circ_0001377 expression in human HF tissues. Its circular structure and subcellular localization were identified using Sanger sequencing, RNase R treatment, and fluorescence in situ hybridization (FISH). Gain- and loss-of-function experiments were conducted to elucidate the role of hsa_circ_0001377 in the human HSC line LX-2. Furthermore, the in vitro and in vivo effects of the hsa_circ_0001377/let-7a-5p/TGFBR1, Smad2, and Col1a2 regulatory axis were investigated using cytological assays and a bile duct ligation (BDL)-induced mouse model of HF. Results : hsa_circ_0001377 was significantly upregulated in the circRNA expression profile of human HF tissues. Its circular structure was validated through Sanger sequencing and resistance to RNase R digestion. FISH and co-staining with α-SMA demonstrated that hsa_circ_0001377 was abundantly expressed in activated HSCs (aHSCs; α-SMA-positive cells). Gain- and loss-of-function assays were performed using LX-2 cells with stable hsa_circ_0001377 overexpression and a specific siRNA targeting this circRNA. hsa_circ_0001377 overexpression promoted LX-2 cell activation, proliferation, migration, and G1/S-phase transition, whereas its knockdown produced the opposite effects. qRT-PCR, AGO-RIP, dual-luciferase reporter, and miRNA pulldown assays confirmed that hsa_circ_0001377 acts as a molecular sponge for let-7a-5p and that let-7a-5p targets TGFBR1, Smad2, and Col1a2. Rescue experiments in LX-2 cells further demonstrated that hsa_circ_0001377 promotes HSC activation, proliferation, migration, and G1/S-phase transition through the let-7a-5p/TGFBR1, Smad2, and Col1a2 axis. Moreover, hsa_circ_0001377 was highly expressed in 20 human HF samples, and its expression increased with advancing fibrosis stage. In vivo , a BDL-induced murine HF model demonstrated that the homologous mmu_circ_0001377 was also significantly upregulated in fibrotic liver tissues. In addition, tail-vein injection of an mmu-let-7a-5p agomir into BDL-induced HF mice confirmed the inhibitory effects of the let-7a-5p/TGFBR1, Smad2, and Col1a2 axis on α-SMA expression and collagen deposition. Conclusion : Taken together, these findings suggest that the hsa_circ_0001377/let-7a-5p/TGFBR1, Smad2, and Col1a2 regulatory axis may represent a promising therapeutic target for HF.
SN - 1663-9812
ER -